Allergan Aesthetics is bringing back its annual BOTOX Cosmetic Day, offering US consumers special promotions through its Allē loyalty programme. The campaign also highlights the growing role of digital loyalty platforms in aesthetic medicine.
BOTOX Cosmetic Day 2026 will take place on Wednesday, 18 November, as Allergan Aesthetics prepares for the eighth edition of its annual US consumer campaign.
The AbbVie-owned company announced the event on 28 October 2026. This year’s campaign includes a buy-one-get-one gift-card offer and a referral programme for members of Allē, its aesthetic treatment loyalty platform.
Beyond the discounts, the event illustrates how pharmaceutical companies are using loyalty programmes to strengthen relationships between patients, aesthetic practitioners and brands.
What Are the BOTOX Cosmetic Day 2026 Offers?
Allergan Aesthetics has announced two promotions for eligible US Allē members.
1. Buy-one-get-one gift cards
On 18 November, beginning at 9 a.m. Pacific Time, members who purchase a $50 BOTOX Cosmetic gift card will receive another $50 gift card at no additional cost.
The offer is available while supplies last. Members can use the cards towards future eligible BOTOX Cosmetic treatments at participating practices.
2. November referral programme
Throughout November, existing Allē members can refer a friend to the platform.
When the referred person registers and receives an eligible treatment during the promotional period, both participants can qualify for a $50 offer towards an eligible Allē product or treatment.
The referral programme allows a maximum of one qualifying referral offer per member.
Both promotions are subject to eligibility requirements and terms. They apply to the US market and should not be interpreted as worldwide offers.
Allē Connects More Than Seven Million Members
According to Allergan Aesthetics, Allē now connects more than seven million members with nearly 30,000 aesthetic practices.
The company says members can earn points on more than 50 treatments and brands outside the Allergan Aesthetics portfolio.
This makes Allē more than a conventional product discount programme.
It also serves as a digital platform for consumer engagement, treatment rewards and relationships with participating providers.
For aesthetic clinics, loyalty programmes may encourage repeat visits and introduce patients to additional services.
However, the company has not disclosed how many practices will participate in this year’s BOTOX Cosmetic Day or how much additional treatment demand the campaign is expected to generate.
Four FDA-Approved Aesthetic Treatment Areas
BOTOX Cosmetic, or onabotulinumtoxinA, received its first US FDA approval for aesthetic use in 2002.
It is currently approved in the United States for the temporary improvement of moderate to severe appearance concerns involving four areas in adults:
- Frown lines between the eyebrows
- Crow’s feet around the eyes
- Forehead lines
- Vertical bands connecting the jaw and neck, known as platysma bands
The company also highlighted results from a Phase 4 study in which 90.5% of treated patients reported being mostly or very satisfied with how natural their upper facial results looked at Day 30.
However, these findings were cited from company-held data rather than a fully reviewed published study in the announcement.
What Does This Mean for the Aesthetic Industry?
BOTOX Cosmetic Day demonstrates how established aesthetic brands are combining consumer marketing with digital loyalty programmes.
Such campaigns may support patient acquisition and retention while strengthening relationships with participating clinics.
At the same time, medical decisions should remain independent of promotional offers.
BOTOX Cosmetic is a prescription medicine. Treatment requires an appropriate clinical assessment, discussion of risks and suitability, and administration by a qualified professional.
Its prescribing information includes warnings about potentially serious adverse effects, including difficulty swallowing, speaking or breathing and the spread of toxin effects.
For patients, a promotional discount should never replace an informed consultation.
For the industry, the November campaign offers another example of how loyalty technology is becoming part of the business model of aesthetic medicine.
Sources and References
Primary source: Allergan Aesthetics / AbbVie. The Countdown Is On: BOTOX Cosmetic (onabotulinumtoxinA) Day Is Back Nov. 18. Published 28 October 2026.
Company newsroom:
Product and promotional information:
This article reports a company announcement. Aesthetics.news has not independently verified the company’s membership figures or unpublished satisfaction-study data.
Medical information disclaimer
This article is published by Aesthetics.news for general information and educational purposes only. It does not constitute medical advice, diagnosis or treatment, and should not replace a consultation with a qualified healthcare professional. Treatments and outcomes may vary from person to person. Readers should seek advice from an appropriately qualified professional before making decisions about their health or treatment. In a medical emergency, seek immediate medical assistance.
